Drugs Custom Duty
- All
- News
-
Tax Cuts On Cancer Drugs, Higher Tobacco Tax Can Boost Public Health: AIIMS Study
The Goods and Services Tax (GST) exemption of lifesaving cancer drugs and higher taxation on tobacco products are the steps aimed at strengthening public health in the country, according to a new study led by oncologists from
-
India's Fight Against Cancer Gets Stronger With Ayushman Arogya Mandir: JP Nadda
Ayushman Arogya Mandirs is strengthening the fight against cancer in India, said Union Health Minister JP Nadda on World Cancer Day on Wednesday.
-
Union Budget 2026 Signals Prevention-Led, Innovation-Driven Healthcare Shift, Say Industry Leaders
Union Budget 2026 places strong emphasis on prevention, biopharma innovation and mental health, with industry leaders highlighting the importance of early screening, stronger regulation and faster access to global medical innovation.
-
Union Budget 2026: 17 Cancer Drugs Get Import Duty Exemption To Cut Costs And Save Lives
The Union Budget 2026-27 has exempted basic customs duty on 17 critical cancer drugs to reduce treatment costs and improve access for patients reliant on expensive imported medicines.
-
Union Budget 2026: How Import Duty Exemption On Rare Disease Drugs Could Make Treatments Cheaper
The Union Budget 2026-27 includes customs duty exemptions on drugs and medical foods used to treat seven rare diseases under India's National Policy for Rare Diseases, potentially lowering costs for patients reliant on imported therapies.
-
Union Budget 2026 Puts Healthcare Growth At Centre With Biopharma, Mental Health, Cancer Care Focus
The Union Budget presented by Finance Minister Nirmala Sitharaman in Parliament on Sunday on healthcare and pharmaceuticals pushed biopharma manufacturing, research, and skilled manpower.
-
Union Budget 2026: Duty Relief On Cancer Drugs, Import Exemptions For Rare Diseases
In the Union Budget 2026, the government announced targeted relief for cancer patients by exempting basic customs duty on 17 essential cancer drugs and medicines, aimed at reducing treatment costs.
-
Cancer Drugs To Get Cheaper In N Sitharaman's Big Budget Announcement
Finance Minister Nirmala Sitharaman announced Saturday that 36 lifesaving drugs and medicines, particularly for cancer patients and those suffering from rare diseases, will be fully exempt from basic customs duty(BCD).
-
Budget 2025: 36 Life-Saving Drugs Fully Exempted From Basic Customs Duty
Budget 2025: 36 life-saving drugs have been fully exempted from basic customs duty, Union Finance Minister Nirmala Sitharaman announced on Saturday.
-
Budget 2024: Centre To Remove Customs Duty On 3 Life-Saving Cancer Medicines
Union Finance Minister Nirmala Sitharaman proposed to completely slash the custom duties on three cancer medicines. Centre has proposed to cut the custom duties on Trastuzumab Deruxtecan, Osimertinib and Durvalumab from 10 per cent to zero.
-
Tax Cuts On Cancer Drugs, Higher Tobacco Tax Can Boost Public Health: AIIMS Study
The Goods and Services Tax (GST) exemption of lifesaving cancer drugs and higher taxation on tobacco products are the steps aimed at strengthening public health in the country, according to a new study led by oncologists from
-
India's Fight Against Cancer Gets Stronger With Ayushman Arogya Mandir: JP Nadda
Ayushman Arogya Mandirs is strengthening the fight against cancer in India, said Union Health Minister JP Nadda on World Cancer Day on Wednesday.
-
Union Budget 2026 Signals Prevention-Led, Innovation-Driven Healthcare Shift, Say Industry Leaders
Union Budget 2026 places strong emphasis on prevention, biopharma innovation and mental health, with industry leaders highlighting the importance of early screening, stronger regulation and faster access to global medical innovation.
-
Union Budget 2026: 17 Cancer Drugs Get Import Duty Exemption To Cut Costs And Save Lives
The Union Budget 2026-27 has exempted basic customs duty on 17 critical cancer drugs to reduce treatment costs and improve access for patients reliant on expensive imported medicines.
-
Union Budget 2026: How Import Duty Exemption On Rare Disease Drugs Could Make Treatments Cheaper
The Union Budget 2026-27 includes customs duty exemptions on drugs and medical foods used to treat seven rare diseases under India's National Policy for Rare Diseases, potentially lowering costs for patients reliant on imported therapies.
-
Union Budget 2026 Puts Healthcare Growth At Centre With Biopharma, Mental Health, Cancer Care Focus
The Union Budget presented by Finance Minister Nirmala Sitharaman in Parliament on Sunday on healthcare and pharmaceuticals pushed biopharma manufacturing, research, and skilled manpower.
-
Union Budget 2026: Duty Relief On Cancer Drugs, Import Exemptions For Rare Diseases
In the Union Budget 2026, the government announced targeted relief for cancer patients by exempting basic customs duty on 17 essential cancer drugs and medicines, aimed at reducing treatment costs.
-
Cancer Drugs To Get Cheaper In N Sitharaman's Big Budget Announcement
Finance Minister Nirmala Sitharaman announced Saturday that 36 lifesaving drugs and medicines, particularly for cancer patients and those suffering from rare diseases, will be fully exempt from basic customs duty(BCD).
-
Budget 2025: 36 Life-Saving Drugs Fully Exempted From Basic Customs Duty
Budget 2025: 36 life-saving drugs have been fully exempted from basic customs duty, Union Finance Minister Nirmala Sitharaman announced on Saturday.
-
Budget 2024: Centre To Remove Customs Duty On 3 Life-Saving Cancer Medicines
Union Finance Minister Nirmala Sitharaman proposed to completely slash the custom duties on three cancer medicines. Centre has proposed to cut the custom duties on Trastuzumab Deruxtecan, Osimertinib and Durvalumab from 10 per cent to zero.
